Valiant Laboratories Board of Directors

Get the latest insights into the leadership at Valiant Laboratories. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Velji K Gogri Chairman & Ind.Director
Mr. Santosh S Vora Managing Director
Mr. Paresh S Shah Executive Director
Mr. Shantilal S Vora Non Executive Director
Mr. Sandeep N Gupta Non Executive Director
Mrs. Sonal A Vira Independent Director
Mr. Mulesh M Savla Independent Director

Valiant Laboratories Share price

VALIANTLAB

85.6

1.29 (-1.48%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:27 IST
BUYSELL
Today's High

88.89

Today's Low

85.00

52 Week Low

69.63

52 Week High

123.60

The current prices are delayed, login to your account for live prices

Valiant Laboratories FAQs

The board at Valiant Laboratories consists of experienced professionals, including Mr. Velji K Gogri , Mr. Santosh S Vora , and others, overseeing the company’s strategic and corporate governance.

Directors at Valiant Laboratories are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Velji K Gogri is the current chairman at Valiant Laboratories.

Executive directors at Valiant Laboratories are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Valiant Laboratories adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Valiant Laboratories, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.